Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer

Investegate announcements from BioNTech SE, Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design

Related Keywords

Germany , United States , Canada , United Kingdom , Sylke Maas , Fosun Pharma , Centers For Disease , Genentech , Twitter , Drug Administration , Exchange Commission , Pfizer , Youtube , Pfizer Inc , European Union , Facebook , Roche Group , Strategy With Study Start , Next Generation Vaccine Candidate Based , Enhanced Spike Protein , Marketing Authorization Holder , Emergency Use Authorization , Coronavirus Disease , Disease Control , Vaccine Adverse Event Reporting System , Fact Sheets , Prescribing Information , Breakthroughs That Change Patient , Annual Report , Looking Information , Factors That May Affect Future , New Technologies , Private Securities Litigation Reform Act , Year Ended December , Investegate Announcements , Investegate Company Announcements , Biontech Se , Lobenewswire , Lobenewswire And Globenewswire , Nw ,